Danimer Scientific Inc (DNMR)

$0.3

-0.02

(-4.92%)▲

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $0.29
    $0.33
    $0.30
    downward going graph

    4.68%

    Downside

    Day's Volatility :13.22%

    Upside

    8.95%

    downward going graph
  • $0.29
    $2.09
    $0.30
    downward going graph

    5.0%

    Downside

    52 Weeks Volatility :86.36%

    Upside

    85.65%

    downward going graph

Returns

PeriodDanimer Scientific IncSector (Materials)Index (Russel 2000)
3 Months
-52.19%
0.1%
0.0%
6 Months
-76.38%
0.0%
0.0%
1 Year
-84.06%
10.0%
0.0%
3 Years
-98.33%
6.0%
-22.3%

Highlights

Market Capitalization
36.2M
Book Value
$2.01
Earnings Per Share (EPS)
-1.23
Wall Street Target Price
1.08
Profit Margin
0.0%
Operating Margin TTM
-245.99%
Return On Assets TTM
-8.8%
Return On Equity TTM
-45.9%
Revenue TTM
39.7M
Revenue Per Share TTM
0.38
Quarterly Revenue Growth YOY
-40.699999999999996%
Gross Profit TTM
2.8M
EBITDA
-69.7M
Diluted Eps TTM
-1.23
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.81
EPS Estimate Next Year
-0.47
EPS Estimate Current Quarter
-0.23
EPS Estimate Next Quarter
-0.22

Analyst Recommendation

Buy
    63%Buy
    36%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Danimer Scientific Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
8
8
Hold
4
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 260.0%

Current $0.30
Target $1.08

Company Financials

FY19Y/Y Change
Revenue
32.3M
-
Net Income
-19.5M
-
Net Profit Margin
-60.33%
-
FY20Y/Y Change
Revenue
47.3M
↑ 46.34%
Net Income
-15.0M
↓ 23.29%
Net Profit Margin
-31.62%
↑ 28.71%
FY21Y/Y Change
Revenue
58.7M
↑ 24.12%
Net Income
-60.1M
↑ 301.54%
Net Profit Margin
-102.31%
↓ 70.69%
FY22Y/Y Change
Revenue
53.2M
↓ 9.41%
Net Income
-179.8M
↑ 199.06%
Net Profit Margin
-337.78%
↓ 235.47%
FY23Y/Y Change
Revenue
46.7M
↓ 12.28%
Net Income
-155.5M
↓ 13.51%
Net Profit Margin
-333.03%
↑ 4.75%
Q1 FY23Q/Q Change
Revenue
11.9M
↓ 22.17%
Net Income
-36.6M
↑ 30.62%
Net Profit Margin
-307.22%
↓ 124.17%
Q2 FY23Q/Q Change
Revenue
12.9M
↑ 7.87%
Net Income
-39.2M
↑ 7.1%
Net Profit Margin
-305.02%
↑ 2.2%
Q3 FY23Q/Q Change
Revenue
10.9M
↓ 14.9%
Net Income
-40.2M
↑ 2.34%
Net Profit Margin
-366.82%
↓ 61.8%
Q4 FY23Q/Q Change
Revenue
10.9M
↓ 0.03%
Net Income
-39.4M
↓ 1.81%
Net Profit Margin
-360.29%
↑ 6.53%
Q1 FY24Q/Q Change
Revenue
10.2M
↓ 6.59%
Net Income
-27.3M
↓ 30.86%
Net Profit Margin
-266.66%
↑ 93.63%
Q2 FY24Q/Q Change
Revenue
7.6M
↓ 25.39%
Net Income
-22.7M
↓ 16.88%
Net Profit Margin
-297.08%
↓ 30.42%
FY19Y/Y Change
Total Assets
144.6M
-
Total Liabilities
128.0M
-
FY20Y/Y Change
Total Assets
546.2M
↑ 277.8%
Total Liabilities
107.3M
↓ 16.17%
FY21Y/Y Change
Total Assets
838.6M
↑ 53.53%
Total Liabilities
338.3M
↑ 215.32%
FY22Y/Y Change
Total Assets
712.3M
↓ 15.06%
Total Liabilities
334.7M
↓ 1.09%
FY23Y/Y Change
Total Assets
730.3M
↑ 2.53%
Total Liabilities
452.3M
↑ 35.14%
Q1 FY23Q/Q Change
Total Assets
778.6M
↑ 9.32%
Total Liabilities
423.0M
↑ 26.4%
Q2 FY23Q/Q Change
Total Assets
744.3M
↓ 4.42%
Total Liabilities
414.0M
↓ 2.14%
Q3 FY23Q/Q Change
Total Assets
721.0M
↓ 3.13%
Total Liabilities
416.7M
↑ 0.66%
Q4 FY23Q/Q Change
Total Assets
730.3M
↑ 1.29%
Total Liabilities
452.3M
↑ 8.54%
Q1 FY24Q/Q Change
Total Assets
688.9M
↓ 5.66%
Total Liabilities
432.8M
↓ 4.3%
Q2 FY24Q/Q Change
Total Assets
666.5M
↓ 3.25%
Total Liabilities
432.5M
↓ 0.07%
FY18Y/Y Change
Operating Cash Flow
323.0K
-
Investing Cash Flow
2.8M
-
Financing Cash Flow
-453.0K
-
FY19Y/Y Change
Operating Cash Flow
-1.7M
↓ 617.96%
Investing Cash Flow
-49.1M
↓ 1846.46%
Financing Cash Flow
53.5M
↓ 11909.71%
FY20Y/Y Change
Operating Cash Flow
-13.8M
↑ 724.69%
Investing Cash Flow
-38.3M
↓ 22.07%
Financing Cash Flow
422.7M
↑ 690.08%
FY21Y/Y Change
Operating Cash Flow
-63.0M
↑ 356.35%
Investing Cash Flow
-336.2M
↑ 778.66%
Financing Cash Flow
306.2M
↓ 27.56%
FY22Y/Y Change
Operating Cash Flow
-61.8M
↓ 1.79%
Investing Cash Flow
-182.5M
↓ 45.72%
Financing Cash Flow
21.8M
↓ 92.9%
Q1 FY23Q/Q Change
Operating Cash Flow
-5.9M
↑ 37.84%
Investing Cash Flow
-16.4M
↓ 46.85%
Financing Cash Flow
91.5M
↓ 7251.48%
Q2 FY23Q/Q Change
Operating Cash Flow
-15.3M
↑ 160.63%
Investing Cash Flow
-6.6M
↓ 59.51%
Financing Cash Flow
-6.5M
↓ 107.11%
Q3 FY23Q/Q Change
Operating Cash Flow
-10.2M
↓ 33.4%
Investing Cash Flow
-2.7M
↓ 59.9%
Financing Cash Flow
-541.0K
↓ 91.69%

Technicals Summary

Sell

Neutral

Buy

Danimer Scientific Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Danimer Scientific Inc
Danimer Scientific Inc
-26.59%
-76.38%
-84.06%
-98.33%
-98.73%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
-3.15%
9.6%
-8.01%
0.6%
24.2%
Linde Plc
Linde Plc
3.39%
-1.81%
18.17%
44.74%
146.67%
Dupont De Nemours Inc
Dupont De Nemours Inc
2.49%
11.17%
4.74%
10.81%
12.24%
Sherwin-williams Company, The
Sherwin-williams Company, The
6.22%
4.69%
33.07%
19.15%
106.97%
Ecolab Inc.
Ecolab Inc.
5.83%
9.12%
34.88%
7.89%
22.05%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Danimer Scientific Inc
Danimer Scientific Inc
9.17
NA
NA
-0.81
-0.46
-0.09
NA
2.01
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
23.76
23.76
1.46
12.34
0.16
0.05
0.03
67.93
Linde Plc
Linde Plc
34.85
34.85
2.57
15.53
0.16
0.07
0.01
79.96
Dupont De Nemours Inc
Dupont De Nemours Inc
104.13
104.13
0.45
3.77
0.01
0.03
0.02
55.9
Sherwin-williams Company, The
Sherwin-williams Company, The
36.63
36.63
3.99
11.49
0.68
0.1
0.01
14.95
Ecolab Inc.
Ecolab Inc.
41.32
41.32
2.38
6.62
0.22
0.07
0.01
23.46
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Danimer Scientific Inc
Danimer Scientific Inc
Buy
$36.2M
-98.73%
9.17
0.0%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
Buy
$60.8B
24.2%
23.76
21.24%
Linde Plc
Linde Plc
Buy
$222.3B
146.67%
34.85
19.49%
Dupont De Nemours Inc
Dupont De Nemours Inc
Buy
$34.0B
12.24%
104.13
5.51%
Sherwin-williams Company, The
Sherwin-williams Company, The
Buy
$91.0B
106.97%
36.63
10.92%
Ecolab Inc.
Ecolab Inc.
Hold
$70.2B
22.05%
41.32
10.95%

Insights on Danimer Scientific Inc

  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 12.86M → 7.62M (in $), with an average decrease of 11.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -40.15M → -22.66M (in $), with an average increase of 22.3% per quarter

  • Vs ECL

    In the last 1 year, Ecolab Inc. has given 34.9% return, outperforming this stock by 119.0%

  • Vs LIN

    In the last 3 years, Linde Plc has given 7.9% return, outperforming this stock by 106.2%

Institutional Holdings

  • Armistice Capital, LLC

    8.67%

  • Vanguard Group Inc

    3.86%

  • Amvescap Plc.

    1.66%

  • Jefferies Financial Group Inc

    1.60%

  • Geode Capital Management, LLC

    1.59%

  • State Street Corporation

    1.54%

Company Information

danimer scientific, producer of biopolymers in bainbridge, ga – manufactures pha bioplastics from renewable, natural resources. danimer plastics are 100% biodegradable and compostable, and equal or exceed petroleum-based plastic commodities for price and performance. danimer, formerly mhg (meredian holdings group), along with agrocrush, create bioplastic feedstock from cold pressed canola oil, enabling global brand owners to utilize environmentally responsible materials in products that consumers purchase every day. danimer makes commercial grade pha using world-class production systems, offering a scalable, durable, and cost effective material that reduces manufacturing dependence on non-renewable, diminishing resources. danimer also offers specialty toll manufacturing at their facility. danimer provides their state of the art production equipment, laboratories, material handling and logistics, as well as their fully trained and experienced staff to other companies.. danimer uses the

Organization
Danimer Scientific Inc
Employees
257
CEO
Mr. Richard J. Hendrix
Industry
Basic Materials

Discover More

FAQs